Skip to Content

130 (Mycophenolate Mofetil 250 mg)

Pill with imprint 130 is Blue & White, Capsule-shape and has been identified as Mycophenolate Mofetil 250 mg. It is supplied by Zydus Pharmaceuticals.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis; graft-versus-host disease and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 130

Mycophenolate mofetil 250 mg 130

Mycophenolate Mofetil

Imprint
130
Strength
250 mg
Color
Blue & White
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals
National Drug Code (NDC)
68382-0130
Inactive Ingredients
croscarmellose sodium, FD&C Blue No. 1, FD&C Red No. 3, magnesium stearate, gelatin, sodium lauryl sulfate, titanium dioxide, povidone k90, pregelatinized corn starch, silicon dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "130"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.